Signing Ceremony

Futian Biopharmaceutical Innovation and R&D Center,  the Chinese University of Hong Kong, Shenzhen aims to deepen the cooperation between Shenzhen and Hong Kong, build a globally competitive biomedical transformation scientific research platform, and promote the development of biomedical industry of Guangdong-Hong Kong-Macao Greater Bay Aera.

The center will provide platform services and talent training for biopharmaceutical research, development and application in four areas: target and innovative drug development, biological big data analysis and application, precision and regenerative medicine research transformation, Chinese medicine modernization and pharmaceutical chemical synthesis, etc.